SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-20-117701
Filing Date
2020-10-23
Accepted
2020-10-23 16:02:23
Documents
71
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a20-34142_110ka.htm 10-K/A 800593
2 EX-23.1 a20-34142_1ex23d1.htm EX-23.1 2968
3 EX-31.1 a20-34142_1ex31d1.htm EX-31.1 10011
4 EX-31.2 a20-34142_1ex31d2.htm EX-31.2 10001
5 EX-32.1 a20-34142_1ex32d1.htm EX-32.1 7397
12 GRAPHIC g341421lei001.jpg GRAPHIC 1936
  Complete submission text file 0001104659-20-117701.txt   5813609

Data Files

Seq Description Document Type Size
6 EX-101.INS mist-20191231.xml EX-101.INS 1478171
7 EX-101.SCH mist-20191231.xsd EX-101.SCH 49738
8 EX-101.CAL mist-20191231_cal.xml EX-101.CAL 49182
9 EX-101.DEF mist-20191231_def.xml EX-101.DEF 188381
10 EX-101.LAB mist-20191231_lab.xml EX-101.LAB 437933
11 EX-101.PRE mist-20191231_pre.xml EX-101.PRE 331175
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38899 | Film No.: 201257770
SIC: 2834 Pharmaceutical Preparations